Vicia faba Extract Isolation for Anticonvulsant Activity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for epilepsy lack effective compounds to inhibit or reduce the incidence, duration, or severity of epileptic seizures, and there is a need for anticonvulsant compounds derived from Vicia faba beans that can provide therapeutic benefits.
Innovation Solution
An extract of Vicia faba beans is prepared by soaking, boiling, homogenizing, filtering, lyophilizing, and then extracting with hexane and ethanol to isolate compounds, specifically sample A-1, which is shown to protect mice from strychnine-induced convulsions with a molecular weight of 200.16447 g/mol and empirical formula C9H16N2O3, and sample A-2, which delays the onset of convulsions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for epilepsy are used, then existing therapeutic options are available, but they lack effective compounds to inhibit or reduce the incidence, duration, or severity of epileptic seizures
Solution Approach 1:
The patent extracts and isolates specific anticonvulsant compounds from Vicia faba beans through a multi-step process including soaking, boiling, homogenizing, filtering, lyophilizing, and chromatographic separation. This extraction principle allows obtaining pure active compounds (samples A-1 and A-2) from the natural source, resolving the contradiction by providing effective seizure-inhibiting compounds that were previously unavailable.
Solution Approach 2:
The patent uses various intermediary substances and methods in the extraction process, including hexane for lipid removal, ethanol for compound extraction, and chromatographic media for separation. These intermediaries enable the isolation of effective anticonvulsant compounds from the complex plant matrix, thereby providing reliable therapeutic agents.
2Quantity of substance
If Vicia faba beans are used as a food source, then nutritional benefits are provided, but antinutritional factors reduce nutrient availability
Solution Approach 1:
The patent removes antinutritional factors and unwanted components from Vicia faba beans through systematic extraction and purification steps. Hexane extraction removes lipids and oils, while ethanol extraction and chromatographic separation isolate the active anticonvulsant compounds, leaving behind antinutritional factors and impurities. This resolves the contradiction by eliminating harmful substances while preserving or enhancing the therapeutic value.
Solution Approach 2:
The patent employs parameter changes in the form of different solvents (hexane, ethanol, water), temperatures (boiling, lyophilization at low temperature), and pH conditions during extraction to selectively remove antinutritional factors while preserving the active anticonvulsant compounds. This selective parameter manipulation resolves the contradiction between removing harmful factors and maintaining nutrient/therapeutic availability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Sample A-1 effectively protects mice from strychnine-induced convulsions to the same extent as phenobarbitone, while sample A-2 provides incomplete but slight protection, indicating potential anticonvulsant activity in epilepsy treatment.
Implementation Method 1
The lyophilized powder is extracted with hexane to remove oils and lipids
Implementation Method 2
The oil-free lyophilized powder is dissolved in ethanol solvent and extracted for eight hours under reflux
Implementation Method 3
The volume of ethanol is reduced by a rotary evaporator
Implementation Method 4
The filtrate is concentrated to a smaller volume, lyophilized, and powdered
Data Source
AI summary
The extract of Vicia faba beans is prepared by soaking beans in distilled water overnight and then boiling in a water bath to reduce the volume of aqueous extract, which is then homogenized and filtered. The filtrate is concentrated to a smaller volume, lyophilized, and powdered. The lyophilized powder is extracted with hexane to remove oils and lipids. The oil-free lyophilized powder is dissolved in ethanol solvent and extracted for eight hours under reflux, and filtered. The volume of ethanol is reduced by a rotary evaporator, and a first off-white precipitate (sample A-1) is collected, washed with ethanol, and dried at 80° C. Mass spectrometry shows a molecular weight of 200.16447 g mol−1, and an empirical formula of C9H16N2O3 is assigned. Intraperitoneal injection of mice with 50 mg/kg of A-1 twenty minutes prior to injection with strychnine protected the mice from strychnine-induced convulsions to the same extent as phenobarbitone (phenobarbital).